Evidence map›Paper›PMID 36525223›Full record

ArticleInternational urology and nephrology2023

Utility of a modified Controlling Nutritional Status score in mortality risk assessment of patients on hemodialysis.

Nobuhisa Morimoto, Kevin Y Urayama, Kiyoshi Ozawa, Hiroyuki Tanaka

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Nobuhisa MorimotoYokosuka Clinic, Yokosuka, Kanagawa, Japan. nobumorimoto836@gmail.com.ORCID http://orcid.org/0000-0002-8330-002X
Kevin Y UrayamaGraduate School of Public Health, St. Luke's International University, Tokyo, Japan.
Kiyoshi OzawaYokosuka Clinic, Yokosuka, Kanagawa, Japan.
Hiroyuki TanakaDepartment of Nephrology, Yokosuka Kyosai Hospital, Yokosuka, Kanagawa, Japan.
St. Luke's International University · JPNaval Hospital Yokosuka Japan · JPYokosuka Kyosai Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMalnutrition is common among hemodialysis patients. A nutritional index may be important for their prognosis prediction. We examined the use of a modified version of the Controlling Nutritional Status (CONUT) score as a predictor of mortality in hemodialysis patients and investigated whether statin use modified the association.

methodsWe conducted a retrospective cohort study in 1130 adults (mean age 67.7 years, 35.0% women) on maintenance hemodialysis at four outpatient dialysis clinics in Japan. The exposure of interest was modified CONUT scores calculated by one-time data of serum albumin and total cholesterol at baseline, or mean data of these measures using multiple blood test results. The primary outcome was all-cause mortality. We examined the association between modified CONUT groups (low-risk, middle-risk, and high-risk) and mortality using multivariate Cox proportional hazard regression and logistic regression models in overall patients and by statin use.

resultsDuring a median follow-up of 6.6 years, 525 (46.5%) patients died. Analysis using both one-time and mean data showed increased mortality risk in the high-risk modified CONUT score group as compared to the low-risk group (mean data: HR 2.52, 95% CI 1.96, 3.24); when stratified by statin use, the effect appeared stronger among users (mean data: HR 5.84, 95% CI 2.98, 11.44). Strong predictive ability was observed, particularly for mortality risk at 5 year follow-up using mean data (AUC = 0.842).

conclusionOur results suggest that the modified CONUT score may be useful in helping clinicians quickly identify hemodialysis patients with poorer prognosis who may benefit from close monitoring and interventions.

Indexed as

Hydroxymethylglutaryl-CoA Reductase InhibitorsMalnutritionAdultAgedFemaleHumansMaleNutritional StatusNutrition AssessmentPrognosisRetrospective StudiesRisk AssessmentHydroxymethylglutaryl-CoA Reductase InhibitorsControlling Nutritional StatusHemodialysisMalnutritionMortalityStatin

Identifiers

PMID36525223
OpenAlexW4311663097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.